UWBCC1POS and UWBCC1NEG cells were grafted into the flank of mice and allowed to establish tumor growth for 4 weeks, when tumors were approximately 10 mm in diameter, and intraperitoneal CD200-blocking antibody was administered daily for 7 days. The gene discussed is CD200; the disease is neoplasm.